» Articles » PMID: 15059949

Genetic Background (C57BL/6J Versus FVB/N) Strongly Influences the Severity of Diabetes and Insulin Resistance in Ob/ob Mice

Overview
Journal Endocrinology
Specialty Endocrinology
Date 2004 Apr 3
PMID 15059949
Citations 91
Authors
Affiliations
Soon will be listed here.
Abstract

We studied the effects of genetic background on the phenotype of ob/ob mice, a model of severe obesity, insulin resistance, and diabetes caused by leptin deficiency. Despite a comparable degree of obesity and hyperinsulinemia, C57BL/6J ob/ob mice had much milder hyperglycemia and, surprisingly, normal circulating adiponectin levels despite still-prominent signs of insulin resistance. Hyperinsulinemic-euglycemic clamp revealed relatively less whole-body and muscle insulin resistance in C57BL/6J ob/ob mice, whereas liver insulin resistance tended to be more severe than in FVB/N ob/ob mice. C57BL/6J ob/ob mice had also more rapid clearance of circulating triglycerides and more severe hepatic steatosis. We suggest that strain-related distinction in lipid handling is the most important player in the differences in diabetic phenotype and insulin sensitivity, whereas the impact of circulating adiponectin levels on the overall phenotype of ob/ob mice is less important.

Citing Articles

Genetic Background Strongly Influences the Impact of Carrying the Thr92Ala-DIO2 Polymorphism in the Male Mouse.

Gabriel de Almeida G, Bolin A, Batistuzzo A, Fonseca T, Ribeiro M, Bianco A Endocrinology. 2024; 165(7).

PMID: 38836615 PMC: 11181002. DOI: 10.1210/endocr/bqae064.


Rodent models to study type 1 and type 2 diabetes induced human diabetic nephropathy.

Talukdar A, Basumatary M Mol Biol Rep. 2023; 50(9):7759-7782.

PMID: 37458869 DOI: 10.1007/s11033-023-08621-z.


The double-hit protocol induces HFpEF and impairs myocardial ubiquitin-proteasome system performance in FVB/N mice.

Lira J, Guymon A, Yang L, Sternburg J, Giri S, Wang X Front Physiol. 2023; 14:1208153.

PMID: 37362441 PMC: 10285383. DOI: 10.3389/fphys.2023.1208153.


Prospects of potential adipokines as therapeutic agents in obesity-linked atherogenic dyslipidemia and insulin resistance.

Roy P, Islam J, Lalhlenmawia H Egypt Heart J. 2023; 75(1):24.

PMID: 37014444 PMC: 10073393. DOI: 10.1186/s43044-023-00352-7.


Mouse strain-dependent variation in metabolic associated fatty liver disease (MAFLD): a comprehensive resource tool for pre-clinical studies.

Karimkhanloo H, Keenan S, Bayliss J, De Nardo W, Miotto P, Devereux C Sci Rep. 2023; 13(1):4711.

PMID: 36949095 PMC: 10033881. DOI: 10.1038/s41598-023-32037-1.